- Home
- OCC vs ACRV Comparison
OCC vs ACRV Comparison
Compare OCC & ACRV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- ACRV
- Stock Information
- Founded
- OCC 1983
- ACRV 2018
- Country
- OCC United States
- ACRV United States
- Employees
- OCC N/A
- ACRV N/A
- Industry
- OCC Telecommunications Equipment
- ACRV Medicinal Chemicals and Botanical Products
- Sector
- OCC Industrials
- ACRV Health Care
- Exchange
- OCC Nasdaq
- ACRV Nasdaq
- Market Cap
- OCC 45.3M
- ACRV 40.4M
- IPO Year
- OCC 1996
- ACRV 2022
- Fundamental
- Price
- OCC $4.98
- ACRV $1.43
- Analyst Decision
- OCC
- ACRV Buy
- Analyst Count
- OCC 0
- ACRV 7
- Target Price
- OCC N/A
- ACRV $17.60
- AVG Volume (30 Days)
- OCC 771.7K
- ACRV 371.9K
- Earning Date
- OCC 09-10-2025
- ACRV 08-12-2025
- Dividend Yield
- OCC N/A
- ACRV N/A
- EPS Growth
- OCC N/A
- ACRV N/A
- EPS
- OCC N/A
- ACRV N/A
- Revenue
- OCC $68,999,601.00
- ACRV N/A
- Revenue This Year
- OCC N/A
- ACRV N/A
- Revenue Next Year
- OCC N/A
- ACRV N/A
- P/E Ratio
- OCC N/A
- ACRV N/A
- Revenue Growth
- OCC 5.77
- ACRV N/A
- 52 Week Low
- OCC $2.02
- ACRV $1.05
- 52 Week High
- OCC $7.00
- ACRV $10.16
- Technical
- Relative Strength Index (RSI)
- OCC 57.45
- ACRV 59.53
- Support Level
- OCC $4.75
- ACRV $1.34
- Resistance Level
- OCC $6.04
- ACRV $1.50
- Average True Range (ATR)
- OCC 0.74
- ACRV 0.08
- MACD
- OCC -0.06
- ACRV 0.01
- Stochastic Oscillator
- OCC 23.75
- ACRV 74.07
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.